期刊文献+

糖尿病及胰岛素应用对维持性血液透析患者血钾水平的影响 被引量:6

The influence of diabetes and insulin on the fluctuation of serum potassium of maintenance hemodialysis patients and nursing experience
原文传递
导出
摘要 目的 观察糖尿病本身以及胰岛素的应用对维持性血液透析(maintenane hemodialysis,MHD)患者的血钾波动有何影响.方法 选取52例维持性血液透析患者,其中30例为非糖尿病患者(非糖尿病组),11例患糖尿病但不使用胰岛素患者(糖尿病不用胰岛素组),1 1例糖尿病使用胰岛素患者(糖尿病用胰岛素组),于透析0、24、48 h时采集52例患者血清样本,比较3组患者血钾波动情况.结果 0、24、48 h时,糖尿病不用胰岛素组相对于非糖尿病组,血钾水平比较差异无统计学意义.0、24、48 h时,糖尿病用胰岛素组相对于糖尿病不用胰岛素组和非糖尿病组,血钾均较低,差异有统计学意义.结论 糖尿病本身对维持性血液透析患者血钾波动无影响,但胰岛素可降低患者透析前血钾水平. Objective To observe the influence of diabetes mellitus or insulin on fluctuations of serum potassium in patients with maintenance hemodialysis.Methods 52 cases of hemodialysis patients,including 30 non-diabetes patients,11 patients with diabetes but not using insulin,11 diabetes patients using insulin.At the time of 0,24,48 h during dialysis,we collected serum samples from the 52 patients,serum potassium was compared among the three groups.Results On 0,24,48 h,serum potassium level of the diabetes but not using insulin group had no significant difference with the non-diabetes group.While in diabetes using insulin group,serum potassium level was lower compared with the non-diabetes group or diabetes not using insulin group.Conclusions Diabetes itself had no effect on serum potassium fluctuations of maintenance hemodialysis (MHD) patients,however,insulin can reduce the pre-dialysis serum potassium levels of MHD patients.
出处 《中国实用护理杂志》 北大核心 2014年第6期29-31,共3页 Chinese Journal of Practical Nursing
关键词 糖尿病 胰岛素 维持性血液透析 Diabetes Insulin Maintenance hemodialysis
  • 相关文献

参考文献12

  • 1Chen W, Wang H, Dang X,et al. Prevalence and risk factors associ- ated with chronic kidney disease in an adult population from southern China[ J ]. Nephrol Dial Transplant, 2009,24:1 205-1 212.
  • 2Rubinstein S,Wang C, Qu W.Occupational risk and chronic kidney disease: apopulation-based study in the United States adult popula- tion[J]. Int J Nephrol Renovasc Dis,2013,6: 53-59.
  • 3王质刚.血液净化学[M].2版.北京:北京科学技术出版社,2002:444-448.
  • 4Putcha N, Allon M. Management of hyperkalemia in dialysis pa- tients [ J ] .Serein Dial, 2007,20 ( 5 ) : 431-439.
  • 5Collin AJ,Foley RN,Herzog C,et al. US renal data system,annual data report[ J ]. Am J Kidney Dis, 2011,57(Suppl 1 ) : 2 006.
  • 6Allon M, Copkney C. Albuterol and insulin for treatment of hyper- kalemia in hemodialysis patients [ J ].Kidney Int, 1990,38 : 869 - 872.
  • 7周新.临床生物化学与检验[M].5版.北京:人民卫生出版社,2008:154-158.
  • 8Evans K, Reddan DN, Szezeeh LA. Nondialytie management of hy- perkalemia and pulmonary edema among end-stage renal disease pa-tients: an evaluation of the evidence [ J ].Semin Dial, 2004,17 : 22 -29.
  • 9Putcha N, Allen M. Management of hyperkalemia in alysis patients[ J ]. Semin Dial, 2007,20:431-439.
  • 10Vereijke TL, Bellersen L, Groneewoud JM,et al. Risk calculation for hyperkalaemia in heart failure patients [ J ]. Neth J Med, 2007,65 : 2008-2011.

共引文献5

同被引文献56

  • 1赵建林,郭献山,王林栋,陈玉凤,孔亚坤,耿秀琴.胰岛素强化治疗对初治2型糖尿病患者生活质量的影响[J].山东医药,2013,53(30):39-40. 被引量:9
  • 2黄彩,周海滨,熊静帆,彭绩,聂绍发,卢祖洵.社区管理糖尿病患者生命质量及其影响因素分析[J].疾病控制杂志,2006,10(1):27-29. 被引量:22
  • 3陆再英,终南山.内科学[M].7版.北京:人民卫生出版社,2012:268-274.
  • 4中华医学会糖尿病学分会.中国2型糖尿病防治指南[M].北京:北京大学医学出版社,2013:447-498.
  • 5Awad H,Alghadir A.Validation of the comprehensive international classification of functioning,disability and health core set for diabetes mellitus:Physical therapists'perspectives[J].American Journal of Physical Medicine and Rehabilitation,2013,92(11):968-979.
  • 6Chenjie Yi,Jung-Hyun Lee,et al.Diagnosis of diabetes mellitus using sialic acid expression of erythrocyte and a microfluidic resistive temperature detector(micro-RTD)[J].Sensors and Actuators,B.Chemical,2014,191:305-312.
  • 7Subhojit Ghosh,S.Maka.A constrained sub-optimal controller for glucose regulation in type 1diabetes mellitus[J].Optimal Control Applications and Methods,2014,35(2):191-203.
  • 8Erdim Sertoglu,Ismail Kurt,Serkan Tapan,et al.Comparison of plasma and erythrocyte membrane fatty acid compositions in patients with end-stage renal disease and type 2diabetes mellitus[J].Chemistry and Physics of Lipids,2014,178:11.
  • 9戴庆,戴荣峰,邵敏洁,张凡.格列美脲联合甘精胰岛素治疗2型糖尿病[J].中国临床医学,2010,17(4):533-534. 被引量:16
  • 10王叶菊,刘红丽.甘精胰岛素联合格列美脲与预混胰岛素治疗2型糖尿病疗效比较[J].陕西医学杂志,2010,39(11):1522-1523. 被引量:11

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部